StageZero Life Sciences Ltd. (SZLSF)
| Market Cap | 3.64M -48.4% |
| Revenue (ttm) | 2.88M -37.6% |
| Net Income | -12.53M |
| EPS | -0.12 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 300 |
| Open | 0.0010 |
| Previous Close | 0.0010 |
| Day's Range | 0.0010 - 0.0117 |
| 52-Week Range | 0.0005 - 0.0234 |
| Beta | 0.34 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |
About StageZero Life Sciences
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company’s lead product is Aristotle, a mRNA-based multi-cancer detection panel that tests blood for multiple discrete cancer. It al... [Read more]
News
StageZero Announces Listing on the NEX Exchange
TORONTO, August 14, 2025 – TheNewswire - (StageZero Life Sciences, Ltd. (the “ Company” or “ StageZero”) (TSX: SZLS) announces that its application for listing on the NEX Exchange (“NEX”) has been app...
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order
TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene ex...
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials under the Failure to File Cease Trade Order
TORONTO, ON / ACCESSWIRE / July 3, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene ex...
StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for s...
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-can...
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results
TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-can...
StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / November 15, 2023 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic ...
StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA
Aristotle and AVRT to be offered to My One Medical Source's Customer Base TORONTO, ON / ACCESSWIRE / November 14, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Comp...
StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings
Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patients TORONTO, ON / ACCESSWIRE / November 7, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("Stage...
StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings
CareOncology partners with The Source Functional Nutrition to offer nutritional guidance to cancer patients. TORONTO, ON / ACCESSWIRE / October 20, 2023 / StageZero Life Sciences, Ltd.
StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024
Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to impr...
StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting
Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - StageZero Life Sciences, Ltd (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all...
StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call
Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special ...
StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational Update
Toronto, Ontario--(Newsfile Corp. - May 16, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detect...
StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update
Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early dete...
StageZero to Issue Q4 2022 Financial Results on Friday March 31
Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 opera...
StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30
Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 opera...
Results from METRICs Study Informs Expansion of StageZero's New Care Oncology Protocol
Launch of New Protocol will now make the connection between patients' metabolic health and cancer outcomes using advanced biomarker testing and interactive digital health platform to actively track pa...
StageZero Life Sciences Announces Change of Date of Special Meeting of Shareholders; Will Combine with AGM in Q2 2023
Toronto, Ontario--(Newsfile Corp. - February 2, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to i...
StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023
TORONTO, ON / ACCESSWIRE / January 12, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the ...
StageZero Life Sciences Ltd. Secures CAD $25 Million Capital Commitment from GEM Global Yield LLC SCS
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON / ACCESSWIRE / November 21, 2022 / StageZero Life Sciences Ltd. ("StageZero" or the "Company") (TSX...
StageZero Life Sciences, Ltd Announces Q3 2022 Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / November 15 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS)(OTCQB:SZLSF), a vertically-integrated healthcare company devoted to improving the early ...
StageZero Announces Solutions for Employers to Help Improve Cancer Outcomes
Personalized support for employees through all stages of the patient journey includes advanced diagnostics, interventional support, and innovative telehealth care TORONTO, ON and RICHMOND, VA / ACCESS...
StageZero Life Sciences, Ltd Announces Q2 2022 Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / August 16, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) (OTCQB:SZLSF), a vertically-integrated healthcare company devoted to improving the early ...
StageZero Life Sciences Announces Results on Resolutions at Annual and Special Meeting
TORONTO, ON / ACCESSWIRE / June 28, 2022 / StageZero Life Sciences, Ltd (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all of the tabl...